Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Decellularized Human Amniotic Membrane Reinforced by Mos2-Polycaprolactone Nanofibers, a Novel Conductive Scaffold for Cardiac Tissue Engineering Publisher Pubmed



Nazari H1 ; Heiranitabasi A2 ; Esmaeili E3, 4 ; Kajbafzadeh AM5 ; Hassannejad Z5 ; Boroomand S2 ; Shahsavari Alavijeh MH6 ; Mishan MA7 ; Ahmadi Tafti SH2 ; Warkiani ME1, 8 ; Dadgar N2, 9
Authors
Show Affiliations
Authors Affiliations
  1. 1. School of Biomedical Engineering, University of Technology Sydney, Sydney, 2007, NSW, Australia
  2. 2. Research Center for Advanced Technologies in Cardiovascular Medicine, Cardiovascular Research Institute, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Stem Cell Technology Research Center, Tehran, Iran
  4. 4. Arta Shimi Alborz Research Center, Tehran, Iran
  5. 5. Pediatric Urology and Regenerative Medicine Research Center, Children's Medical Center, Pediatric Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Department of Mechanical Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran
  7. 7. Ocular Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  8. 8. Institute of Molecular Medicine, Sechenov University, Moscow, 119991, Russian Federation
  9. 9. Department of Colorectal Surgery, Digestive Disease Surgerical Institute, Cleveland Clinic, Cleveland, OH, United States

Source: Journal of Biomaterials Applications Published:2022


Abstract

In order to regenerate myocardial tissues with functional characteristics, we need to copy some properties of the myocardium, such as its extracellular matrix and electrical conductivity. In this study, we synthesized nanosheets of Molybdenum disulfide (MoS2), and integrated them into polycaprolactone (PCL) and electrospun on the surface of decellularized human amniotic membrane (DHAM) with the purpose of improving the scaffolds mechanical properties and electrical conductivity. For in vitro studies, we seeded the mouse embryonic cardiac cells, mouse Embryonic Cardiac Cells (mECCs), on the scaffolds and then studied the MoS2 nanocomposites by scanning electron microscopy and Raman spectroscopy. In addition, we characterized the DHAM/PCL and DHAM/PCL-MoS2 by SEM, transmission electron microscopy, water contact angle measurement, electrical conductivity, and tensile test. Besides, we confirmed the scaffolds are biocompatible by 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide, MTT assay. Furthermore, by means of SEM images, it was shown that mECCs attached to the DHAM/PCL-MoS2 scaffold have more cell aggregations and elongated morphology. Furthermore, through the Real-Time PCR and immunostaining studies, we found out cardiac genes were maturated and upregulated, and they also included GATA-4, c-TnT, NKX 2.5, and alpha-myosin heavy chain in cells cultured on DHAM/PCL-MoS2 scaffold in comparison to DHAM/PCL and DHAM. Therefore, in terms of cardiac tissue engineering, DHAM nanofibrous scaffolds reinforced by PCL-MoS2 can be suggested as a proper candidate. © The Author(s) 2022.
Other Related Docs
16. The Role of Nanomaterials in Cell Delivery Systems, Medical Molecular Morphology (2018)
19. Decellularizing Bone Tissue: Various Protocols, Regenerative Engineering and Translational Medicine (2024)